Understanding the complexity of acute myeloid leukemia (AML)
A new era of treatment for elderly acute myeloid leukemia (AML) patients?
Hagop M. Kantarjian
Cell therapy - progress to date and next steps
Matched unrelated donor (MUD) transplantations for ALL and AML
Safety of ponatinib in chronic-phase chronic myeloid leukemia (CML) patients
Michael J. Mauro